<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Matrix metalloproteinase-7 is capable of degrading many extracellular matrix proteins and cellular <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesions</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In many <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, it is overexpressed, and it plays a role in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> by enhancing <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> invasion and thereby metastatic potential </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study was to evaluate the association between MMP-7 tissue expression and prognosis in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>From 623 patients who underwent surgery for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, surgical specimens were collected into tissue array blocks and stained by immunohistochemistry for MMP-7 </plain></SENT>
<SENT sid="4" pm="."><plain>Specimens from 545 patients were suitable for analysis </plain></SENT>
<SENT sid="5" pm="."><plain>In specimens from 105 patients (19.3%), MMP-7 scored as high; in 103 (18.9%), as moderate; and in 134 (24.9%), as mild </plain></SENT>
<SENT sid="6" pm="."><plain>In 203 cases (37.2%), immunoreactivity was negative </plain></SENT>
<SENT sid="7" pm="."><plain>A significant correlation appeared between MMP-7 immunoexpression and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation </plain></SENT>
<SENT sid="8" pm="."><plain>High MMP-7 positivity associated with poor prognosis during a 5-year follow-up </plain></SENT>
<SENT sid="9" pm="."><plain>During longer follow-up, the differences in survival between groups disappeared </plain></SENT>
<SENT sid="10" pm="."><plain>MMP-7 is a potential target for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> therapy, which should be evaluated in clinical trials </plain></SENT>
</text></document>